Patents were recently granted in 12 new countries for SULIDIN® LPS® (Topical Nimesulide Gel). Licensees are sought in these and other territories worldwide. More
APR Applied Pharma Research sa ("APR") and Labtec GmbH ("Labtec") announce the successful completion of the Pivotal Bioequivalence study for their proprietary Ondansetron RapidFilm™ More
APR Applied Pharma Research SA., together with its joint venture partner Labtec GmbH, announce the signature of an exclusive licensing agreement with BioAlliance Pharma SA. for Ondansetron RapidFilm™ for Europe More
The German R&D Company Labtec GmbH and the Swiss R&D Company APR Applied Pharma Research S.A. have recently partnered together for the further development, registration and licensing out of a high tech., top of the art NSAID topical patch for More
Rapid In-vitro Percutaneous Penetration Profile of Sulidin® 1% Nimesulide LPS topical gel to be presented at the 8'th International Conference on Percutaneous Penetration. More
All rights reserved. Terms and Conditions | Contact us
